Immunoglobulin subclasses prophylactic use immunoglobulin immunoglobulin subclass deficiency Persistent low serum levels several immunoglobulin IgG high proportion adult patients increased susceptibility infections hard low subclass level responsible susceptibility healthy blood donors devoid certain subclasses serum apparent discrepancy observation subclass-deficient patients underlying aberrations T-cell B-cell interaction function capacity minor deficiencies prospective blind crossover study effect prophylactic Ig substitution therapy adult patients IgG subclass deficiency patients year therapy intramuscular Ig mg/kg/wk year saline injections significant protective effect prophylactic Ig therapy great reduction number days infection addition several immunologic parameters year Ig therapy Nineteen patients open study mg/kg/wk Ig months treatment significant protection infection reduction days number days month infection marked effect prophylactic Ig Ig aberrations IgG subclass-deficient patients susceptibility infection effect mg/kg/wk pronounced mg/kg/wk normal serum IgG subclass levels higher-dose therapy likely subcutaneous intravenous administration doses Ig efficient therapy 